| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROCE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 0.93 | — | 8.1% | 0.48 | ₹-18 cr | 10.3 | 0.96 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 34 | 1 | 0.35 | -7.9% | +24.8% | 2.0% |
| Mar 2026 | 30 | 1 | 0.39 | -51.2% | +53.0% | 2.5% |
| Dec 2025 | 27 | 0 | 0.24 | -36.8% | +100.2% | 0.9% |
| Sep 2025 | 28 | 0 | 0.15 | -90.5% | +54.0% | 1.0% |
| Jun 2025 | 27 | 1 | 0.38 | -61.6% | +50.6% | 2.6% |
| Mar 2025 | 20 | 1 | 0.80 | -66.7% | +0.9% | 3.5% |
| Dec 2024 | 13 | 1 | 0.38 | -7.3% | +59.9% | 4.9% |
| Sep 2024 | 18 | 1 | 1.58 | turnaround | +92.0% | 6.6% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✗ Fail |
| EPS growth positive and accelerating over 3 consecutive quarters | ✗ Fail |
| Sales up 25%+, or sales growth positive and accelerating | ✗ Fail |
| Annual EPS up 25%+ in each of the last 2 years (3 full years needed) | — Not assessable |
| Net margin above the same quarter last year | ✗ Fail |
| Quarter | Promoters | FIIs | DIIs | Retail & others | Promoter shares pledged |
|---|---|---|---|---|---|
| Oct 2026 | 45.26% | 1.85% | 0.00% | 52.89% | 0.00% |
| Sep 2026 | 41.65% | 1.98% | 0.00% | 56.37% | 0.00% |
| Jun 2026 | 41.65% | 2.21% | 0.00% | 56.14% | 0.00% |
| Mar 2026 | 41.31% | 2.21% | 0.00% | 56.48% | 0.00% |
| Dec 2025 | 41.31% | 2.21% | 0.00% | 56.48% | 40.58% |
| Sep 2025 | 41.31% | 2.21% | 0.00% | 56.48% | 0.00% |
| Jun 2025 | 41.31% | 2.45% | 0.00% | 56.24% | 40.58% |
| Apr 2025 | 41.31% | 2.45% | 0.00% | 56.24% | 0.00% |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✓ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✓ Close above the 50-day ✓ At least 25% above the 52-week low · low 24.49 ✓ Within 25% of the 52-week high · high 41.13 ✗ RS percentile 70 or more · RS 55 Minervini's trend template - the gate the scanner applies. | 4/8 | 4 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 1 - basing | |
| CAN SLIM | ✗ C latest quarter EPS up 25%+, with sales up 25%+ or accelerating — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N (proxy) near the 52-week high - within 15% · high 41.13 ✓ S (proxy) more volume on up days than down days (50 sessions) · 2.90x ✗ L RS percentile 80 or more · RS 55 ✗ I (proxy) FII + DII holding trend · 1.9% vs 2.0% (-0.13 pp, 2026-09 -> 2026-10) ✓ M (proxy) market in an uptrend, 40%+ of stocks above their 200-day - shared, not counted · breadth 51% William O'Neil's growth-leader checklist, as a checklist score: the six stock letters counted equally, though O'Neil read them together. M is the market condition, shown but not counted. N, S, I and M are proxies. | 1/5 | Weak |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 34.20 ✗ Close above the prior 20-session high · 33.00 ✗ Close below the prior 20-session low (also a Turtle exit level) · 27.00 Turtle-inspired long breakout: the Turtle traders' entry channels only - no exits, stops or position sizing. | No signal | |
| Greenblatt | — Earnings yield (EBIT / enterprise value) · 7.5% — Return on capital (filed ROCE - adapted) · 8.1% Joel Greenblatt's Magic Formula, adapted: a relative ranking among non-financial, non-utility companies above Rs 500 crore. Return on capital uses filed ROCE, not Greenblatt's tangible-capital measure. Strong = top 30% of that ranking, not a test passed. | 36/100 | Weak |
| Graham | ✓ Price at or below the Graham number · Graham number 40.53 · price / Graham number 0.78 · 3-year average EPS ✓ P/E 15 or less · P/E 14.9 on 3-year average EPS ✓ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 0.93 · P/E x P/B 13.8 ✓ Current ratio 2 or more · 2.19 ✓ Long-term debt no more than net current assets · debt 18,512,000 · net current assets 650,983,000 ✓ Positive earnings in every full year held · 3 years held (Graham asked 10) — 20 years of dividends, 10-year earnings growth, adequate size · not assessed Graham number valuation: the price against sqrt(22.5 x EPS x book value per share). Graham's defensive tests are listed separately; this is not his full defensive screen. | Below Graham number | |
| Piotroski | ✓ Profitable (ROA > 0, on beginning-of-year assets) ✗ Operating cash flow positive — ROA rising · needs three years ✗ Cash flow above net profit (earnings quality) — Long-term debt / average assets lower · needs three years ✗ Current ratio higher · 2.19 ✗ No new equity issued · share capital x1.11, bonus/split x1.00 — Gross margin higher · not assessed - gross profit not filed here — Asset turnover higher (sales / beginning assets) · needs three years Piotroski F-score (adapted), FY 2025 -> 2026: 1 of 9 passed, 4 not assessed. Piotroski applied it to value stocks; here it is shown for all non-financial companies. | 1/9 | Weak |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAIPURKURT this stock | +7.4 | +15.2 | -2.6 | -10.4 | -59.3 | -40.1 | — | 0.93 | — | — | — | — | — | — | — | — | — | 0.96 |
| SCPL | +4.6 | +4.7 | +43.9 | +190.1 | +86.0 | — | 30.2 | 4.05 | 13.2 | — | — | 0.57 | 15.6 | 677 | 395 | 22 | 21.3 | 0.47 |
| PREMIERPOL | -11.4 | +31.1 | +58.6 | +125.5 | +178.8 | +516.3 | 25.9 | 5.75 | 24.1 | 32.9 | 17.42 | 0.00 | 19.9 | 965 | 396 | 37 | 3.5 | 0.57 |
| CALSOFT | -27.0 | +35.9 | +136.9 | +63.2 | +107.3 | -14.3 | 12.2 | 4.33 | 32.3 | 42.0 | 27.61 | 0.04 | — | — | 25 | 15 | 2.4 | 0.62 |
| VALIANTLAB | +0.6 | +107.2 | +61.7 | +52.1 | -37.7 | — | 42.7 | 2.20 | -1.2 | 0.8 | -0.76 | 0.14 | 84.8 | 683 | 306 | 16 | 3.0 | 0.80 |
| DIGJAMLMTD | +36.9 | +33.1 | +37.2 | +50.8 | -22.1 | +45.1 | 66.4 | 19.70 | -20.3 | 5.2 | -1.28 | 9.10 | 41.2 | 130 | 33 | 2 | 1.0 | 0.93 |
| CHEMBONDCH | +6.0 | -0.3 | +26.4 | +48.5 | — | — | 18.0 | 2.83 | 17.6 | — | — | 0.01 | 10.9 | 612 | 370 | 34 | 12.7 | 1.32 |
| NILKAMAL | +23.6 | +17.5 | +70.2 | +46.4 | -1.1 | -8.5 | 20.6 | 2.00 | 7.5 | 10.0 | 4.59 | 0.16 | 10.0 | 3,275 | 3,873 | 159 | 106.5 | 0.71 |
| AKSHARCHEM | -2.9 | +51.0 | +89.2 | +38.3 | +45.2 | -25.4 | 10.5 | 1.04 | -0.2 | 0.7 | -0.10 | 0.36 | 8.0 | 303 | 488 | 29 | 35.8 | 0.81 |
| 21STCENMGM | +67.7 | +55.6 | +74.2 | +36.0 | +253.1 | +10.7 | — | 1.14 | 33.3 | 36.8 | 28.65 | 0.00 | 3.2 | 67 | — | — | — | 0.31 |
| MARALOVER | +3.6 | +7.2 | +31.5 | +29.6 | -15.9 | -23.3 | — | 2.21 | — | — | — | — | — | — | — | — | — | 1.02 |
← All NSE stocks · More Other stocks